Quantitative analysis of retroviral and lentiviral gene transfer to murine embryonic stem cells

被引:4
|
作者
Chilton, Jamie M. [2 ]
Le Doux, Joseph M. [1 ,2 ]
机构
[1] Georgia Tech & Emory Univ, Wallace H Coulter Dept Biomed Engn, Petit Inst Bioengn & Biosci, IBB, Atlanta, GA 30332 USA
[2] Georgia Inst Technol, Georgia Tech Emory Ctr Engn Living Tissues, Atlanta, GA 30332 USA
关键词
Gene therapy; Lentivirus; Retrovirus; Gene expression; Transduction efficiency; Embryonic stem cells;
D O I
10.1016/j.jbiotec.2008.07.1996
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The effectiveness of retrovirus or lentivirus transduction of embryonic stem (ES) cells is often limited because transgene expression is silenced or variegated. We wondered if other steps of transduction, in addition to gene expression, were restricted in ES cells. We quantitatively compared (1) the amount of virus binding, (2) the number of integrated transgenes, and (3) the resulting level of gene expression. We found that three- to fourfold fewer retroviruses and lentiviruses bound to R1 mES cells than to NIH 3T3 cells, suggesting that both types of viruses bind less efficiently to mES cells. Retroviruses and lentiviruses differed in the efficiency with which they completed post-binding steps of transduction. In R1 mES cells, we detected 3-fold fewer integrated retrovirus transgenes and 11-fold lower expression levels than in NIH 3T3 cells, which suggests that the primary limitation to retrovirus transduction may be low levels of transgene expression. In contrast, we detected 10-fold fewer integrated lentivirus transgenes and 8-fold lower expression levels in R1 mES cells than in NIH 3T3 cells, which suggests that lentivirus transduction may be limited by inefficient intracellular post-binding steps of transduction. The implications of our findings for developing improved viral vectors for transducing mES cells are discussed. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:42 / 51
页数:10
相关论文
共 50 条
  • [1] Optimization of lentiviral gene transfer to human embryonic stem cells
    Lutzko, C
    Yu, XJ
    Kohn, DB
    BLOOD, 2002, 100 (11) : 220A - 220A
  • [2] Retroviral β-globin gene transfer into murine hematopoietic stem cells.
    Atweh, GF
    BLOOD CELLS MOLECULES AND DISEASES, 2000, 26 (05) : 491 - 491
  • [3] Efficient gene transfer into murine embryonic stem cells by nucleofection
    Peer Lorenz
    Ulf Harnack
    Rudolf Morgenstern
    Biotechnology Letters, 2004, 26 : 1589 - 1592
  • [4] Efficient gene transfer into murine embryonic stem cells by nucleofection
    Lorenz, P
    Harnack, U
    Morgenstern, R
    BIOTECHNOLOGY LETTERS, 2004, 26 (20) : 1589 - 1592
  • [5] Optimization of Vector Design for Lentiviral Gene Transfer into Human Embryonic Stem Cells
    Aizawa, Emi
    Mitsui, Kaoru
    Suzuki, Keiichiro
    Suemori, Hirofumi
    Nakatsuji, Norio
    Mitani, Ko
    MOLECULAR THERAPY, 2009, 17 : S265 - S265
  • [6] Improved lentiviral gene transfer into human embryonic stem cells grown in co-culture with murine feeder and stroma cells
    Wurm, Melanie
    Gross, Benjamin
    Sgodda, Malte
    Staendker, Ludger
    Mueller, Thomas
    Forssmann, Wolf-Georg
    Horn, Peter A.
    Blasczyk, Rainer
    Cantz, Tobias
    BIOLOGICAL CHEMISTRY, 2011, 392 (10) : 887 - 895
  • [7] Comparison of gene-trapping efficiency between retroviral and lentiviral vectors in mouse embryonic stem cells
    Yamaguchi, Tomoyuki
    Morikawa, Azusa
    Miyoshi, Hiroyuki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 425 (02) : 297 - 303
  • [8] Lentiviral gene transfer into human and murine hematopoietic stem cells: Size matters
    Canté-Barrett K.
    Mendes R.D.
    Smits W.K.
    Van Helsdingen-Van Wijk Y.M.
    Pieters R.
    Meijerink J.P.P.
    BMC Research Notes, 9 (1)
  • [9] Insertional leukemogenesis after retroviral gene transfer into murine hematopoietic stem cells
    Brugman, MH
    Verstegen, MMA
    Visser, TP
    Fränzel-Luiten, E
    Schmidt, M
    Wognum, AW
    von Kalle, C
    Wagemaker, G
    MOLECULAR THERAPY, 2004, 9 : S401 - S401
  • [10] Genetic modification of murine embryonic stem cells by the gene silencing resistance retroviral vector GCDsap
    Hamanaka, S
    Usui, J
    Takahashi, S
    Yoshida, H
    Nagata, M
    Otsu, M
    Kaneko, S
    Nagasawa, T
    Nakauchi, H
    Onodera, M
    MOLECULAR THERAPY, 2004, 9 : S125 - S125